Navigation Links
Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum
Date:10/1/2013

orable safety profile. Inovio's lead vaccine, a therapeutic against HPV-caused pre-cancers and cancers, is in phase II. Other phase I and preclinical programs target prostate, breast, and lung cancers as well as HIV, influenza, malaria and hepatitis. Partners and collaborators include Roche, the University of Pennsylvania, Merck, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, University of Southampton, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatmen
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 According to a ... Trauma Fixation Devices Market - Global Forecast, Market Share, ... global orthopedic trauma fixation devices market is estimated at ... grow at a CAGR of 7.2% from 2014 to ... billion in 2020. Browse the Orthopedic Trauma ...
(Date:7/29/2014)...  Instrumentation Laboratory (IL) today announced the launch of its ... is part of a comprehensive rebranding effort by Werfen, the ... Boston, MA , in 1959, IL has been part ... companies in the group include Inova Diagnostics ( San ... Spain ).  Like IL, these three companies are focused ...
(Date:7/29/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering. ... device is a medical device used to provide medication ... breathing and cannot achieve adequate oxygen levels to maintain ... asthma, COPD, and ARDS require the need of respiratory ...
Breaking Medicine Technology:Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3Global Respiratory Devices Market 2014-2018 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 New high ... Medicare Part D by a projected $2.9 to $5.8 ... the actuarial firm Milliman released today by the Pharmaceutical ... D premiums could increase by as much as 8.6 ... C drugs, including Sovaldi and Olysio. , The study ...
(Date:7/29/2014)... Law Offices of Michael Cordova is proud to announce the ... grief camps for kids, teens, adults, and families. We ... from the death of a loved one. Therefore, it ... of Hope, as they provide hope and healing to people ... a monthly support group and a variety of overnight weekend ...
(Date:7/29/2014)... that helps headache sufferers to record the severity and ... of a Griffith research study. , A new approach ... at coping with their triggers and is being led ... Basis of Health program. , He has developed an ... triggers of their headaches called Learning to Cope with ...
(Date:7/29/2014)... to cure most cases of cancer is to surgically ... however, is that the surgeon may fail to extract ... With a new technique, researchers at the University of ... see the entire tumor in the patient, increasing the ... an injectable dye that accumulates in cancerous tissues much ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 A new ... during the 2014 Society for Cardiovascular Angiography and Interventions ... released this week. The videos review the benefits of ... services for the cardiac catheterization laboratory from the perspective ... the first video, Jane Kiah, MS, RN, Director of ...
Breaking Medicine News(10 mins):Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3
... , March 15 The Board of Directors of Healthcare Trust of America, Inc. ("HTA"), ... June 2010 .  These distributions will be calculated based on the stockholders of record each day ... $10.00 . , ... ...
... The nation,s theater owners were asked today by the head of a major Hollywood studio to have healthier snacks at their concession stands in addition to their traditional ... ... ... ...
... people who suffer a break up to eight times more likely ... Older men and women who break a hip are five to ... after the fracture, a new study by Belgian researchers has found. ... substantially during the first two years after the break, it never ...
... from Boston University School of Medicine (BUSM) believe teaching ... into internal medicine residency training and can be done ... on-line in BioMedCentral Medical Education , represent a ... residents. Unhealthy substance use can be serious and ...
... , CHICAGO , March 15 ... submitted its detailed responses on two major regulations that ... and Reinvestment Act of 2009 (ARRA).  One comment addressed ... (ONC) Interim Final Rule (IFR) on EHR certification criteria ...
... The effect might be strongest after menopause, mouse study ... have believed that testosterone and estrogen play a major ... in mice suggests that female sex chromosomes could also ... the study, researchers genetically engineered male mice to have ...
Cached Medicine News:Health News:Healthcare Trust of America Board of Directors Declares Distributions 2Health News:Healthcare Trust of America Board of Directors Declares Distributions 3Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 2Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 3Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 4Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 5Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 6Health News:Risk of Death Persists After a Hip Fracture 2Health News:Risk of Death Persists After a Hip Fracture 3Health News:Researchers recommend curriculum on unhealthy substance use 2Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 2Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 3Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 4Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 5Health News:Women's Chromosomes May Affect Blood Pressure 2
Silicone ICD lead...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... The SOLX DeepLight Glaucoma ... invasive, yet highly effective glaucoma ... our DeepLight Gold Micro-Shunt (GMS) ... Laser that help use the ...
The Verity ADx pacemaker family, which includes the world's longest lasting single- and dual-chamber pacemakers, provides clinicians with a variety of feature options and header configurations to mee...
Medicine Products: